ARS Pharmaceuticals, Inc.

NasdaqGM:SPRY Stock Report

Market Cap: US$1.4b

ARS Pharmaceuticals Ownership

Who are the major shareholders and have insiders been buying or selling?

Recent Insider Transactions

NasdaqGM:SPRY Recent Insider Transactions by Companies or Individuals
DateValueNameEntityRoleSharesMax Price
26 Aug 24SellUS$1,088,035OrbiMed Advisors LLCCompany83,695US$13.00
23 Aug 24SellUS$11,497,963OrbiMed Advisors LLCCompany868,682US$14.61
27 Mar 24BuyUS$13,289,410RA Capital Management, L.P.Company1,401,299US$9.79

Insider Trading Volume

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.

Ownership Breakdown

What is the ownership structure of SPRY?
Owner TypeNumber of SharesOwnership Percentage
Private Companies2,845,9462.94%
Hedge Funds11,077,92711.4%
General Public12,237,39612.6%
Individual Insiders19,120,91719.7%
VC/PE Firms19,149,48719.8%
Institutions32,509,93633.5%

Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.

Top Shareholders

Top 25 shareholders own 80.93% of the company
OwnershipNameSharesCurrent ValueChange %Portfolio %
11.4%
Deerfield Management Company, L.P. Series C
11,077,927US$158.6m0%2.43%
11.2%
RA Capital Management, L.P.
10,860,977US$155.5m0%1.79%
8.55%
OrbiMed Advisors LLC
8,288,510US$118.7m-10.3%1.67%
5.89%
Richard Lowenthal
5,711,807US$81.8m-2.56%no data
4.98%
Pratik Shah
4,824,554US$69.1m-52.5%no data
4.35%
Robert Bell
4,213,504US$60.3m0%no data
4.21%
BlackRock, Inc.
4,084,339US$58.5m53.7%no data
4.14%
SR One Capital Management, LP
4,012,903US$57.5m0%10.73%
3.52%
Sarina Tanimoto
3,407,847US$48.8m0%no data
3.35%
The Vanguard Group, Inc.
3,250,927US$46.6m12.6%no data
3.04%
Franklin Resources, Inc.
2,950,709US$42.3m0%0.01%
2.94%
The Lowenthal-Tanimoto Family Trust
2,845,946US$40.8m-13.7%no data
2.54%
K2 & Associates Investment Management Inc.
2,461,672US$35.3m10.9%16.53%
1.97%
Nextech Invest Ltd.
1,910,029US$27.4m0%4.08%
1.91%
State Street Global Advisors, Inc.
1,856,221US$26.6m15.7%no data
1.23%
Geode Capital Management, LLC
1,195,878US$17.1m36.4%no data
1.12%
FMR LLC
1,085,318US$15.5m0.04%no data
0.89%
Perceptive Advisors LLC
867,319US$12.4m0%0.28%
0.72%
Medical Strategy GmbH, Asset Management Arm
696,665US$10.0m9.03%0.57%
0.67%
Royce & Associates, LP
645,700US$9.2m15.6%0.08%
0.66%
Rubric Capital Management LP
639,203US$9.2m0%0.15%
0.43%
Charles Schwab Investment Management, Inc.
415,530US$6.0m20.3%no data
0.42%
Invesco Capital Management LLC
406,188US$5.8m1.67%no data
0.39%
Valerie Odegard
382,236US$5.5m0%no data
0.38%
Jacobs Levy Equity Management Inc
365,027US$5.2m31.4%0.02%